Prevention of Polymerization of M and Z α1-Antitrypsin ( α1-AT) with Trimethylamine N-Oxide
- 1 June 2001
- journal article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 24 (6), 727-732
- https://doi.org/10.1165/ajrcmb.24.6.4407
Abstract
Alpha1-Antitrypsin (alpha1-AT) is the most abundant circulating proteinase inhibitor. The Z variant results in profound plasma deficiency as the mutant polymerizes within hepatocytes. The retained polymers are associated with cirrhosis, and the lack of circulating protein predisposes to early onset emphysema. We have investigated the role of the naturally occurring solute trimethylamine N-oxide (TMAO) in modulating the polymerization of normal M and disease-associated Z alpha1-AT. TMAO stabilized both M and Z alpha1-AT in an active conformation against heat-induced polymerization. Spectroscopic analysis demonstrated that this was due to inhibition of the conversion of the native state to a polymerogenic intermediate. However, TMAO did not aid the refolding of denatured alpha1-AT to a native conformation; instead, it enhanced polymerization. These data show that TMAO can be used to control the conformational transitions of folded alpha1-AT but that it is ineffective in promoting folding of the polypeptide chain within the secretory pathway.Keywords
This publication has 37 references indexed in Scilit:
- Probing the Unfolding Pathway of α1-AntitrypsinPublished by Elsevier BV ,1999
- A Kinetic Mechanism for the Polymerization of α1-AntitrypsinPublished by Elsevier BV ,1999
- Implications for function and therapy of a 2.9 å structure of binary-complexed antithrombinJournal of Molecular Biology, 1998
- Conformational diseaseThe Lancet, 1997
- Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpinsProtein Science, 1997
- COOH-terminal Substitutions in the Serpin C1 Inhibitor That Cause Loop Overinsertion and Subsequent MultimerizationPublished by Elsevier BV ,1995
- Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.JCI Insight, 1995
- Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)JCI Insight, 1994
- The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung diseaseJournal of Hepatology, 1993
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986